Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Donner

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
Journal of Medicinal Chemistry|March 28, 1997
Structure-activity studies for a novel series of N-(arylethyl)-N-(1,2,3,4-tetrahydronaphthalen-1-ylmethyl)-N-methylamine s possessing dual 5-HT uptake inhibiting and alpha2-antagonistic activitiesM D Meyer, A A Hancock, K Tietje, et al.
Journal of Medicinal Chemistry|July 4, 1997
(1 alpha, 2 beta, 3 beta, 4 alpha)-1,2-bis[N-propyl-N-(4-phenoxybenzyl) amino]carbonyl]cyclobutane-3,4-dicarboxylic acid (A-87049): a novel potent squalene synthase inhibitorA K Fung, W R Baker, S Fakhoury, et al.
Journal of Clinical Epidemiology|August 28, 1999
The prevention education program (PEP). A prospective study of the efficacy of family-oriented life style modification in the reduction of cardiovascular risk and disease: design and baseline dataP Schwandt, H C Geiss, M M Ritter, et al.
Frontiers in Physiology|March 11, 2020
Defining the Progression of Diabetic Cardiomyopathy in a Mouse Model of Type 1 DiabetesMiles J De Blasio, Nguyen Huynh, Minh Deo, et al.
Cardiovascular Drugs and Therapy|October 21, 2024
Acute Inhibition of Drp1 Mitigates Adverse Cardiac Remodelling following Chronic Reperfused Myocardial InfarctionDaniel G Donner, Anne M Kong, Jarmon G Lees, et al.
Clinical Chemistry|November 1, 1992
Effects of angiotensinase inhibitors on plasma protein binding and IC50 determinations of renin inhibitorsB D Dayton, H H Stein, J Cohen, et al.
Frontiers in Pharmacology|October 25, 2021
Bone Morphogenetic Protein 7 Gene Delivery Improves Cardiac Structure and Function in a Murine Model of Diabetic CardiomyopathyMitchel Tate, Nimna Perera, Darnel Prakoso, et al.
Biological Chemistry|October 26, 2012
HbG200-mediated preinduction of heme oxygenase-1 improves bile flow and ameliorates pericentral downregulation of Bsep and Mrp2 following experimental liver ischemia and reperfusionMarkus G Donner, Stefan A Topp, Patricia Cebula, et al.
Endocrinology|February 8, 2026
Balcinrenone shows a unique regulation of potassium excretion in streptozotocin-induced diabetes in male miceMonica Kanki, Elliott Vivekanantham, Gregory H Tesch, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 3, 2018
Galectin-3 deficiency ameliorates fibrosis and remodeling in dilated cardiomyopathy mice with enhanced Mst1 signalingMy-Nhan Nguyen, Mark Ziemann, Helen Kiriazis, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Journal of Medicinal Chemistry|March 28, 1997
Structure-activity studies for a novel series of N-(arylethyl)-N-(1,2,3,4-tetrahydronaphthalen-1-ylmethyl)-N-methylamine s possessing dual 5-HT uptake inhibiting and alpha2-antagonistic activitiesM D Meyer, A A Hancock, K Tietje, et al.
Journal of Medicinal Chemistry|July 4, 1997
(1 alpha, 2 beta, 3 beta, 4 alpha)-1,2-bis[N-propyl-N-(4-phenoxybenzyl) amino]carbonyl]cyclobutane-3,4-dicarboxylic acid (A-87049): a novel potent squalene synthase inhibitorA K Fung, W R Baker, S Fakhoury, et al.
Journal of Clinical Epidemiology|August 28, 1999
The prevention education program (PEP). A prospective study of the efficacy of family-oriented life style modification in the reduction of cardiovascular risk and disease: design and baseline dataP Schwandt, H C Geiss, M M Ritter, et al.
Frontiers in Physiology|March 11, 2020
Defining the Progression of Diabetic Cardiomyopathy in a Mouse Model of Type 1 DiabetesMiles J De Blasio, Nguyen Huynh, Minh Deo, et al.
Cardiovascular Drugs and Therapy|October 21, 2024
Acute Inhibition of Drp1 Mitigates Adverse Cardiac Remodelling following Chronic Reperfused Myocardial InfarctionDaniel G Donner, Anne M Kong, Jarmon G Lees, et al.
Clinical Chemistry|November 1, 1992
Effects of angiotensinase inhibitors on plasma protein binding and IC50 determinations of renin inhibitorsB D Dayton, H H Stein, J Cohen, et al.
Frontiers in Pharmacology|October 25, 2021
Bone Morphogenetic Protein 7 Gene Delivery Improves Cardiac Structure and Function in a Murine Model of Diabetic CardiomyopathyMitchel Tate, Nimna Perera, Darnel Prakoso, et al.
Biological Chemistry|October 26, 2012
HbG200-mediated preinduction of heme oxygenase-1 improves bile flow and ameliorates pericentral downregulation of Bsep and Mrp2 following experimental liver ischemia and reperfusionMarkus G Donner, Stefan A Topp, Patricia Cebula, et al.
Endocrinology|February 8, 2026
Balcinrenone shows a unique regulation of potassium excretion in streptozotocin-induced diabetes in male miceMonica Kanki, Elliott Vivekanantham, Gregory H Tesch, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 3, 2018
Galectin-3 deficiency ameliorates fibrosis and remodeling in dilated cardiomyopathy mice with enhanced Mst1 signalingMy-Nhan Nguyen, Mark Ziemann, Helen Kiriazis, et al.
Pageof 10